Table 2.
Head-to-head comparisons of efficacy of FMT.
| A | 0.83(0.15,4.64) | 0.51(0.05,5.09) | 0.17 (0.01,3.51) | 0.11(0.02,0.5) | 0.14(0.01,2.64) | 0.20 (0.01,3.15) |
| 1.21 (0.22,6.77) | B | 0.62 (0.11,3.38) | 0.20 (0.01,6.67) | 0.13(0.03,0.72) | 0.17 (0.01,2.53) | 0.24 (0.02,2.97) |
| 1.95 (0.20,19.44) | 1.62 (0.30,8.85) | C | 0.33 (0.01,14.79) | 0.22 (0.02,2.19) | 0.28 (0.01,6.49) | 0.38 (0.02,7.83) |
| 6.00 (0.28,126.34) | 4.97(0.15,164.69) | 3.07 (0.07,139.57) | D | 0.67(0.02,20.74) | 0.86(0.01,58.13) | 1.18 (0.02,72.65) |
| 8.98 (1.84,43.92) | 7.44(1.39,39.75) | 4.60 (0.46,46.37) | 1.50 (0.05,46.49) | E | 1.28(0.09,18.32) | 1.77(0.14,21.87) |
| 7.01 (0.38,129.38) | 5.80(0.40,85.13) | 3.59 (0.15,83.50) | 1.17 (0.02,79.25) | 0.78(0.05,11.14) | F | 1.38 (0.04,44.62) |
| 5.08 (0.32,81.14) | 4.21(0.34,52.48) | 2.60 (0.13,52.91) | 0.85 (0.01,52.04) | 0.57 (0.05,6.99) | 0.72(0.02,23.45) | G |
(A) fresh fecal bacteria; (B) frozen fecal bacteria; (C) lyophilized fecal bacteria; (D) autologous fecal bacteria; (E) vancomycin; (F) fidaxomicin; (G) rectal bacteriotherapy.